MedPath

成都倍特药业股份有限公司

Ownership
-
Established
1995-10-10
Employees
-
Market Cap
-
Website
http://www.btyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

364

NMPA:364

Drug Approvals

Carbazochrome Sodium Sulfonate Tablets

Product Name
卡络磺钠片
Approval Number
国药准字H20254419
Approval Date
Jun 3, 2025
NMPA

Voriconazole for Oral Suspension

Product Name
伏立康唑干混悬剂
Approval Number
国药准字H20254249
Approval Date
May 27, 2025
NMPA

Sodium Thiosulfate Injection

Product Name
硫代硫酸钠注射液
Approval Number
国药准字H20254180
Approval Date
May 13, 2025
NMPA

Carbazochrome Sodium Sulfonate Tablets

Product Name
卡络磺钠片
Approval Number
国药准字H20254018
Approval Date
Apr 30, 2025
NMPA

Cetylpyridinium Chloride Buccal Tablets

Product Name
西吡氯铵含片
Approval Number
国药准字H20253837
Approval Date
Apr 8, 2025
NMPA

Ceftazidime and Avibactam Sodium for Injection

Product Name
注射用头孢他啶阿维巴坦钠
Approval Number
国药准字H20253763
Approval Date
Apr 1, 2025
NMPA

Iomeprol Injection

Product Name
碘美普尔注射液
Approval Number
国药准字H20253479
Approval Date
Feb 25, 2025
NMPA

Drotaverine Hydrochloride Injection

Product Name
盐酸屈他维林注射液
Approval Number
国药准字H20253456
Approval Date
Feb 25, 2025
NMPA

Iomeprol Injection

Product Name
碘美普尔注射液
Approval Number
国药准字H20249738
Approval Date
Dec 17, 2024
NMPA

Nimodipine Injection

Product Name
尼莫地平注射液
Approval Number
国药准字H20249601
Approval Date
Dec 1, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 37
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.